LG G Pad 5 10.1 FHD Owners Manual - Page 139

International Electro Magnetic Fields EMF Project since its inception in 1996., Frequency RF energy.

Page 139 highlights

of the studies that showed increased tumor development used animals that had been genetically engineered or treated with cancer-causing chemicals so as to be pre-disposed to develop cancer in the absence of RF exposure. Other studies exposed the animals to RF for up to 22 hours per day. These conditions are not similar to the conditions under which people use wireless devices, so we do not know with certainty what the results of such studies mean for human health. Three large epidemiology studies have been published since December 2000. Between them, the studies investigated any possible association between the use of wireless devices and primary brain cancer, glioma, meningioma, or acoustic neuroma, tumors of the brain or salivary gland, leukemia, or other cancers. None of the studies demonstrated the existence of any harmful health effects from wireless device RF exposures. However, none of the studies can answer questions about long-term exposures, since the average period of device use in these studies was around three years. 5. What research is needed to decide whether RF exposure from devices poses a health risk? A combination of laboratory studies and epidemiological studies of people actually using devices would provide some of the data that are needed. Lifetime animal exposure studies could be completed in a few years. However, very large numbers of animals would be needed to provide reliable proof of a cancer promoting effect if one exists. Epidemiological studies can provide data that is directly applicable to human populations, but ten or more years follow-up may be needed to provide answers about some health effects, such as cancer. This is because the interval between the time of exposure to a cancer-causing agent and the time tumors develop - if they do - may be many, many years. The interpretation of epidemiological studies is hampered by difficulties in measuring actual RF exposure during day-to-day use of devices. Many factors affect this measurement, such as the angle at which the device is held, or which model of device is used. 6. What is the FDA doing to find out more about the possible health effects of device RF? The FDA is working with the U.S. National Toxicology Program and with groups of investigators around the world to ensure that high priority animal studies are conducted to address important questions about the effects of exposure to Radio Frequency (RF) energy. The FDA has been a leading participant in the World Health Organization International Electro Magnetic Fields (EMF) Project since its inception in 1996. An influential result of this work has been the development of a detailed agenda For Your Safety 138

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150

For Your Safety
138
of the studies that showed increased tumor development used animals that had
been genetically engineered or treated with cancer-causing chemicals so as to
be pre-disposed to develop cancer in the absence of RF exposure. Other studies
exposed the animals to RF for up to 22 hours per day. These conditions are not
similar to the conditions under which people use wireless devices, so we do not
know with certainty what the results of such studies mean for human health. Three
large epidemiology studies have been published since December 2000. Between
them, the studies investigated any possible association between the use of wireless
devices and primary brain cancer, glioma, meningioma, or acoustic neuroma, tumors
of the brain or salivary gland, leukemia, or other cancers. None of the studies
demonstrated the existence of any harmful health effects from wireless device RF
exposures. However, none of the studies can answer questions about long-term
exposures, since the average period of device use in these studies was around three
years.
5. What research is needed to decide whether RF exposure from devices
poses a health risk?
A combination of laboratory studies and epidemiological studies of people actually
using devices would provide some of the data that are needed. Lifetime animal
exposure studies could be completed in a few years. However, very large numbers
of animals would be needed to provide reliable proof of a cancer promoting effect
if one exists. Epidemiological studies can provide data that is directly applicable
to human populations, but ten or more years follow-up may be needed to
provide answers about some health effects, such as cancer. This is because the
interval between the time of exposure to a cancer-causing agent and the time
tumors develop — if they do — may be many, many years. The interpretation of
epidemiological studies is hampered by difficulties in measuring actual RF exposure
during day-to-day use of devices. Many factors affect this measurement, such as
the angle at which the device is held, or which model of device is used.
6. What is the FDA doing to find out more about the possible health effects
of device RF?
The FDA is working with the U.S. National Toxicology Program and with groups
of investigators around the world to ensure that high priority animal studies are
conducted to address important questions about the effects of exposure to Radio
Frequency (RF) energy.
The FDA has been a leading participant in the World Health Organization
International Electro Magnetic Fields (EMF) Project since its inception in 1996.
An influential result of this work has been the development of a detailed agenda